アクセシビリティ
アニメーション
アクセシビリティ

ACR Convergence 2024 (American College of Rheumatology)

November 14th-19th 2024

Committed to finding answers in rheumatology

Washington, D.C. | Nov. 14-19 | Booth 2318

 

Image
Scientist pulling a sample from a vail


More than 50 years of experience in rheumatology testing and protocols

Join us at ACR Convergence 2024 to learn more about our leading rheumatology services, listen in to a Lightning Talk on anti-DFS70 antibodies, and view our latest posters on rheumatoid arthritis testing patterns and therapeutic drug monitoring of the adalimumab biosimilar adalimumab-atto.

Saturday, Nov. 16, 2024 | 10:30 AM-12:30 PM ET | Poster Session A

0158: Rheumatoid Arthritis Testing Patterns by Physicians and Advanced Practice Providers from a National Commercial Laboratory, 2014 – 2023

Karis Lee, Min Kyung Lee, David Alfego, Kristen Clark, Stanley Naides

Meet author: Karis Lee, MSN, FNP-C

Saturday, Nov. 16, 2024 | 10:30 AM-12:30 PM ET | Poster Session A

0465: Therapeutic Drug Monitoring of the Adalimumab Biosimilar (AMJEVITA™, Adalimumab-atto) Using Originator Adalimumab and Anti-Adalimumab Antibody Assays

Monique Bastidas, Lythou Yeo, Susie Magpantay, Judah Scott, Mike Zikry, Wayne Galdamez, Jane Yang, Kelly Chun

Meet presenter: Rubio Punzalan, MD, PhD

Sunday, Nov. 17, 2024 | 11:47 AM ET | Booth 3257 Wifi Way

Lightning Talk: The Clinical Relevance of Anti-DFS70 Autoantibodies

A novel marker that may help identify individuals who do not have an ANA-associated autoimmune rheumatic disease especially in the absence of significant clinical findings

Meet speaker: Vincent Ricchiuti, PhD